Skip to Main Content

Clover Health Investments, Corp

CLOV Real Time Price USD
N/A
N/A
N/A
...
Overview
Financials
Insiders
Institutions
Government
Income
Balance Sheet
Cash Flow
CLOV Income Statement
CLOV Balance Sheet
CLOV Cash Flow

Recent trades of CLOV by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard
CLOV Stock Insider Trading Activity
Name
Type
Shares
Price
Shares Held
Date
Reported
CLOV Stock Institutional Owners
Investor
Shares
Change in Shares
Market Value
Date
Reported
CLOV Derivatives Institutional Owners
Investor
Type
Shares
Change in Shares
Market Value
Date
Reported

Recently reported changes by institutional investors

Quarterly net insider trading by CLOV's directors and management

Government lobbying spending instances

  • $40,000 Oct 18, 2024 Issue: Health Issues Medicare/Medicaid
  • $40,000 Jul 19, 2024 Issue: Health Issues Medicare/Medicaid
  • $40,000 Apr 19, 2024 Issue: Health Issues Medicare/Medicaid
  • $40,000 Jan 19, 2024 Issue: Health Issues Medicare/Medicaid
  • $40,000 Oct 20, 2023 Issue: Health Issues Medicare/Medicaid
  • $40,000 Jul 20, 2023 Issue: Health Issues Medicare/Medicaid
  • $40,000 Apr 20, 2023 Issue: Health Issues Medicare/Medicaid
  • $40,000 Jan 20, 2023 Issue: Health Issues Medicare/Medicaid
  • $40,000 Oct 19, 2022 Issue: Health Issues Medicare/Medicaid
  • $40,000 Jul 20, 2022 Issue: Health Issues Medicare/Medicaid
  • $40,000 Apr 20, 2022 Issue: Medicare/Medicaid Health Issues
  • $30,000 Jan 19, 2022 Issue: Health Issues Medicare/Medicaid
  • $30,000 Oct 18, 2021 Issue: Medicare/Medicaid Health Issues
  • $30,000 Jul 19, 2021 Issue: Medicare/Medicaid Health Issues
  • $30,000 Apr 19, 2021 Issue: Medicare/Medicaid Health Issues
  • $30,000 Jan 19, 2021 Issue: Medicare/Medicaid Health Issues
  • $30,000 Oct 20, 2020 Issue: Medicare/Medicaid Disaster Planning/Emergencies
  • $30,000 Sep 16, 2020 Issue: Medicare/Medicaid
  • $30,000 Jul 15, 2020 Issue: Medicare/Medicaid Disaster Planning/Emergencies
  • $30,000 Apr 15, 2020 Issue: Medicare/Medicaid
  • $30,000 Oct 17, 2019 Issue: Medicare/Medicaid
  • $30,000 Jul 19, 2019 Issue: Medicare/Medicaid
  • $30,000 Apr 19, 2019 Issue: Medicare/Medicaid
  • $30,000 Jan 18, 2019 Issue: Medicare/Medicaid
  • $30,000 Oct 19, 2018 Issue: Medicare/Medicaid
  • $30,000 Jul 19, 2018 Issue: Medicare/Medicaid
  • $30,000 Apr 19, 2018 Issue: Medicare/Medicaid
  • $30,000 Jan 19, 2018 Issue: Medicare/Medicaid
  • $30,000 Oct 19, 2017 Issue: Medicare/Medicaid
  • $30,000 Jul 20, 2017 Issue: Medicare/Medicaid
  • $30,000 Apr 13, 2017 Issue: None
  • $10,000 Jan 24, 2017 Issue: None
  • $10,000 Apr 19, 2016 Issue: Medicare/Medicaid
  • $10,000 Jan 20, 2016 Issue: Medicare/Medicaid

Estimated quarterly lobbying spending

U.S. Patents

New patents grants

Quiver Logo

No new patents for this ticker

U.S. Patents Dashboard
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard
Government Contracts

Estimated quarterly amount awarded from public contracts

Quiver Logo

No recent Government Contracts for this ticker

Government Contracts Dashboard
WallStreetBets

Number of mentions of CLOV in WallStreetBets Daily Discussion

CLOV News

Recent insights relating to CLOV

CNBC Recommendations

Recent picks made for CLOV stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in CLOV

CLOV Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?

Sign Up to view CLOV Smart Score

Score Breakdown
Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.

Show More
Back To Top